Gentel plans to add 50 new kits to its product portfolio by the end of the year, as it transforms itself from being a services-oriented business to one that derives the bulk of its sales from products.
The collaboration covers Protein Biotechnologies' SomaPlex arrays and Gentel Bioscience's APiX View Detection Kits, which were launched this week.
Illumina's VeraCode ADME Core Panel, Aushon Biosystems' human vascular injury panels, BioServe and Protein Biotechnologies' SomaPlex reverse-phase protein microarrays
The SomaPlex Reverse Phase Protein Microarray is the first product stemming from a collaboration between the two firms, and additional arrays are planned for launch throughout 2010.
Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.
The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.
CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.
In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.